Details
Stereochemistry | RACEMIC |
Molecular Formula | C20H19N3O4S |
Molecular Weight | 397.4494 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cn1c2cc(ccc2nc1COc3ccc(cc3)CC4C(=NC(=O)S4)O)OC
InChI
InChIKey=XMSXOLDPMGMWTH-UHFFFAOYSA-N
InChI=1S/C20H19N3O4S/c1-23-16-10-14(26-2)7-8-15(16)21-18(23)11-27-13-5-3-12(4-6-13)9-17-19(24)22-20(25)28-17/h3-8,10,17H,9,11H2,1-2H3,(H,22,24,25)
Molecular Formula | C20H19N3O4S |
Molecular Weight | 397.4494 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
Rivoglitazone hydrochloride (CS-011) is a thiazolidinedione-derivative peroxisome proliferator–activated receptor (PPAR)-γ agonist. It has been developed as potential treatment in type 2 diabetes mellitus and was shown to decrease plasma glucose and triglyceride levels in a dose-dependent manner in animals. Phase II and III clinical studies have assessed the efficacy and safety of rivoglitazone hydrochloride in patients with type 2 diabetes mellitus.
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Jun 26 00:04:50 UTC 2021
by
admin
on
Sat Jun 26 00:04:50 UTC 2021
|
Record UNII |
3A3N0634Q6
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C98241
Created by
admin on Sat Jun 26 00:04:51 UTC 2021 , Edited by admin on Sat Jun 26 00:04:51 UTC 2021
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
SUB129557
Created by
admin on Sat Jun 26 00:04:51 UTC 2021 , Edited by admin on Sat Jun 26 00:04:51 UTC 2021
|
PRIMARY | |||
|
RIVOGLITAZONE
Created by
admin on Sat Jun 26 00:04:51 UTC 2021 , Edited by admin on Sat Jun 26 00:04:51 UTC 2021
|
PRIMARY | |||
|
C521549
Created by
admin on Sat Jun 26 00:04:51 UTC 2021 , Edited by admin on Sat Jun 26 00:04:51 UTC 2021
|
PRIMARY | |||
|
185428-18-6
Created by
admin on Sat Jun 26 00:04:51 UTC 2021 , Edited by admin on Sat Jun 26 00:04:51 UTC 2021
|
PRIMARY | |||
|
C72841
Created by
admin on Sat Jun 26 00:04:51 UTC 2021 , Edited by admin on Sat Jun 26 00:04:51 UTC 2021
|
PRIMARY | |||
|
DB09200
Created by
admin on Sat Jun 26 00:04:51 UTC 2021 , Edited by admin on Sat Jun 26 00:04:51 UTC 2021
|
PRIMARY | |||
|
8081
Created by
admin on Sat Jun 26 00:04:51 UTC 2021 , Edited by admin on Sat Jun 26 00:04:51 UTC 2021
|
PRIMARY | |||
|
3A3N0634Q6
Created by
admin on Sat Jun 26 00:04:51 UTC 2021 , Edited by admin on Sat Jun 26 00:04:51 UTC 2021
|
PRIMARY | |||
|
3055168
Created by
admin on Sat Jun 26 00:04:51 UTC 2021 , Edited by admin on Sat Jun 26 00:04:51 UTC 2021
|
PRIMARY | |||
|
CHEMBL2104753
Created by
admin on Sat Jun 26 00:04:51 UTC 2021 , Edited by admin on Sat Jun 26 00:04:51 UTC 2021
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
TARGET -> AGONIST |
SELECTIVE
|
||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE -> PARENT |
IN VITRO
|
||
|
METABOLITE -> PARENT |
IN VITRO
|
||
|
METABOLITE -> PARENT |
IN VITRO
|
||
|
METABOLITE -> PARENT |
IN VITRO
|
||
|
METABOLITE -> PARENT |
IN VITRO
|
||
|
METABOLITE -> PARENT |
IN VITRO
|
||
|
METABOLITE -> PARENT |
IN VITRO
|
||
|
METABOLITE -> PARENT |
IN VITRO
|
||
|
METABOLITE -> PARENT |
IN VITRO
|
||
|
METABOLITE -> PARENT |
IN VITRO
|
||
|
METABOLITE -> PARENT |
IN VITRO
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |